UK biotech company ‘Initial Public Offerings’ (IPOs) are raising more than twice as much in 2017 than in 2016, according to report by BioIndustry Association (BIA) and Informa Pharma Intelligence.
UK biotech company IPOs are raising more than twice as much money in 2017 than in 2016 – image courtesy of Depositphotos. BIA CEO, Steve Bates, said: “The UK’s impressive preclinical and clinical pipeline shows the strength and capability of the UK biotech ecosystem to produce fantastic science that attracts talent…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
